SCHEMBL16357541

SCHEMBL16357541

c1ccc(-n2ccc3ccc4c(c5ccccc5n4-c4cc(-c5cccnc5)ccn4)c32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ COMT P21964 1/20 0.37
▸ CYP11B2 P19099 4/20 0.35
▸ CYP11B1 P15538 3/20 0.35
▸ CYP17A1 P05093 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ MAPT P10636 6/20 0.34
▸ HTR1D P28221 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ PDE4A P27815 2/20 0.33
▸ PDE4B Q07343 2/20 0.33
▸ PDE4C Q08493 2/20 0.33
▸ PDE4D Q08499 2/20 0.33
▸ PDE3B Q13370 2/20 0.33
▸ PDE3A Q14432 2/20 0.33
▸ PDE5A O76074 1/20 0.33
▸ KHK P50053 1/20 0.33
▸ PIK3CA P42336 1/20 0.32
▸ KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20426230 0.92 COMT (0.37) COMTCYP11B2CYP11B1CYP17A1CYP19A1
SCHEMBL16357509 0.88 G6PD (0.38) CYP11B2CYP11B1CYP17A1CYP19A1MAPT
SCHEMBL16357333 0.88 COMT (0.40) COMTCYP11B2CYP11B1CYP17A1CYP19A1
SCHEMBL16357566 0.88 CYP19A1 (0.44) CYP11B2CYP11B1CYP19A1MAPT
SCHEMBL16357329 0.87 MAPT (0.38) COMTCYP11B2CYP11B1CYP17A1CYP19A1
SCHEMBL16357470 0.86 MAPT (0.36) CYP11B2CYP11B1CYP17A1CYP19A1MAPT
SCHEMBL15802141 0.85 COMT (0.37) COMTCYP11B2CYP11B1MAPTGSK3B
SCHEMBL15801473 0.84 COMT (0.36) COMTCYP11B2CYP11B1CYP17A1CYP19A1
SCHEMBL20426233 0.84 MAPT (0.36) CYP11B2CYP11B1CYP17A1CYP19A1MAPT
SCHEMBL20426242 0.84 KDM4E (0.36) COMTMAPTPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU COMT 84/4885CYP11B2 888/4885CYP11B1 949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback